David B Karpf is Chief Medical Officer of LUMOS PHARMA, INC.. Currently has a direct ownership of 8,294 shares of LUMO, which is worth approximately $35,830. The most recent transaction as insider was on Feb 01, 2023, when has been sold 36 shares (Common Stock) at a price of $3.52 per share, resulting in proceeds of $126. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.29K
0% 3M change
0% 12M change
Total Value Held $35,830

David B Karpf Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 01 2023
SELL
Payment of exercise price or tax liability
$126 $3.52 p/Share
36 Reduced 0.43%
8,294 Common Stock
Feb 01 2023
BUY
Grant, award, or other acquisition
$3,520 $3.52 p/Share
1,000 Added 10.72%
8,330 Common Stock
Sep 01 2022
SELL
Payment of exercise price or tax liability
$4,862 $8.53 p/Share
570 Reduced 7.22%
7,330 Common Stock
Feb 01 2022
BUY
Grant, award, or other acquisition
$4,008 $10.02 p/Share
400 Added 4.82%
7,900 Common Stock
DBK

David B Karpf

Chief Medical Officer
Austin, TX

Track Institutional and Insider Activities on LUMO

Follow LUMOS PHARMA, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LUMO shares.

Notify only if

Insider Trading

Get notified when an Lumos Pharma, Inc. insider buys or sells LUMO shares.

Notify only if

News

Receive news related to LUMOS PHARMA, INC.

Track Activities on LUMO